Abstract
Posttranslational modification of peptide antigens has been shown to alter the ability of T cells to recognize major histocompatibility complex (MHC) class I–restricted peptides. However, the existence and origin of naturally processed phosphorylated peptides presented by MHC class I molecules have not been explored. By using mass spectrometry, significant numbers of naturally processed phosphorylated peptides were detected in association with several human MHC class I molecules. In addition, CD8+ T cells could be generated that specifically recognized a phosphorylated epitope. Thus, phosphorylated peptides are part of the repertoire of antigens available for recognition by T cells in vivo.
Bibliography
Zarling, A. L., Ficarro, S. B., White, F. M., Shabanowitz, J., Hunt, D. F., & Engelhard, V. H. (2000). Phosphorylated Peptides Are Naturally Processed and Presented by Major Histocompatibility Complex Class I Molecules in Vivo. The Journal of Experimental Medicine, 192(12), 1755â1762.
References
50
Referenced
182
10.1146/annurev.iy.11.040193.002155
/ Annu. Rev. Immunol. / The biochemistry and cell biology of antigen processing and presentation by Germain (1993)10.1111/j.1600-065X.1999.tb01353.x
/ Immunol. Rev. / The nature of the MHC class I peptide loading complex by Cresswell (1999)10.1016/0952-7915(94)90028-0
/ Curr. Opin. Immunol. / Structure of peptides associated with MHC class I molecules by Engelhard (1994)10.1002/(SICI)1097-0215(19990827)82:5<669::AID-IJC9>3.0.CO;2-#
/ Int. J. Cancer. / Mass-spectrometric evaluation of HLA-A*0201-associated peptides identifies dominant naturally processed forms of CTL epitopes from MART-1 and gp100 by Skipper (1999)10.1126/science.1546328
/ Science. / Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry by Hunt (1992)10.4049/jimmunol.151.5.2572
/ J. Immunol. / Characteristics of endogenous peptides eluted from the class I MHC molecule HLA-B7 determined by mass spectrometry and computer modeling by Huczko (1993){'key': '2023072509173878700_R7', 'first-page': '105', 'article-title': 'Analysis of the structure of naturally processed peptides bound by class I and class II major histocompatibility complex molecules', 'volume': '73', 'author': 'Appella', 'year': '1995', 'journal-title': 'Exper. Suppl. (Basel).'}
/ Exper. Suppl. (Basel). / Analysis of the structure of naturally processed peptides bound by class I and class II major histocompatibility complex molecules by Appella (1995){'key': '2023072509173878700_R8', 'first-page': '127', 'article-title': 'Sequence analysis of peptides presented to the immune system by class I and class II MHC molecules', 'volume-title': 'Methods in Protein Analysis', 'author': 'Hunt', 'year': '1993'}
/ Methods in Protein Analysis / Sequence analysis of peptides presented to the immune system by class I and class II MHC molecules by Hunt (1993){'key': '2023072509173878700_R9', 'first-page': '152', 'article-title': 'Isolation and characterization of naturally processed peptides bound by class II molecules and peptides presented by normal and mutant antigen-presenting cells', 'volume': '57', 'author': 'Sette', 'year': '1993', 'journal-title': 'Chem. Immunol.'}
/ Chem. Immunol. / Isolation and characterization of naturally processed peptides bound by class II molecules and peptides presented by normal and mutant antigen-presenting cells by Sette (1993)10.1084/jem.183.2.527
/ J. Exp. Med. / An HLA-A2–restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins by Skipper (1996)10.1084/jem.187.1.37
/ J. Exp. Med. / The class I antigen-processing pathway for the membrane protein tyrosinase involves translation in the endoplasmic reticulum and processing in the cytosol by Mosse (1998)10.1016/S1074-7613(00)80330-1
/ Immunity. / The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition by Meadows (1997)10.4049/jimmunol.160.5.2099
/ J. Immunol. / Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residuesimplications for tumor vaccine development by Kittlesen (1998)10.4049/jimmunol.163.12.6360
/ J. Immunol. / Cutting edgethe HLA-A*0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique by Pierce (1999)10.1084/jem.190.1.145
/ J. Exp. Med. / Presentation of cytosolic glycosylated peptides by human class I major histocompatibility complex molecules in vivo by Haurum (1999)10.1128/jvi.66.7.3996-4002.1992
/ J. Virol. / Posttranslational side chain modification of a viral epitope results in diminished recognition by specific T cells by Larson (1992)10.1084/jem.189.11.1757
/ J. Exp. Med. / Modification of cysteine residues in vitro and in vivo affects the immunogenicity and antigenicity of major histocompatibility complex class I–restricted viral determinants by Chen (1999){'key': '2023072509173878700_R18', 'first-page': '5144', 'article-title': 'The peptide recognized by HLA-A68.2-restricted, squamous cell carcinoma of the lung-specific cytotoxic T lymphocytes is derived from a mutated elongation factor 2 gene', 'volume': '58', 'author': 'Hogan', 'year': '1998', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / The peptide recognized by HLA-A68.2-restricted, squamous cell carcinoma of the lung-specific cytotoxic T lymphocytes is derived from a mutated elongation factor 2 gene by Hogan (1998)10.4049/jimmunol.163.7.3812
/ J. Immunol. / Phosphorylated peptides can be transported by TAP molecules, presented by class I MHC molecules, and recognized by phosphopeptide-specific CTL by Andersen (1999){'key': '2023072509173878700_R20', 'first-page': '2731', 'article-title': 'Cytotoxic T-lymphocyte response to autologous human squamous cell cancer of the lungepitope reconstitution with peptides extracted from HLA-Aw68', 'volume': '54', 'author': 'Slingluff', 'year': '1994', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Cytotoxic T-lymphocyte response to autologous human squamous cell cancer of the lungepitope reconstitution with peptides extracted from HLA-Aw68 by Slingluff (1994)10.1007/BF00375376
/ Immunogenetics. / Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids by Salter (1985)10.1126/science.1546329
/ Science. / HLA-A2.1-associated peptides from a mutant cell linea second pathway of antigen presentation by Henderson (1992)10.4049/jimmunol.152.8.3862
/ J. Immunol. / Association of human class I MHC alleles with the adenovirus E3/19K protein by Beier (1994)10.4049/jimmunol.134.6.4218
/ J. Immunol. / Construction of novel class I histocompatibility antigens by interspecies exon shuffling by Engelhard (1985)10.1016/0198-8859(81)90065-3
/ Hum. Immunol. / Partial purification and some properties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28 by Parham (1981)10.4049/jimmunol.123.1.342
/ J. Immunol. / Use of a monoclonal antibody (W6/32) in structural studies of HLA-A, B, C antigens by Parham (1979)10.1111/j.1399-0039.1983.tb01176.x
/ Tissue Antigens. / Structural and genetic analyses of HLA class I molecules using monoclonal xenoantibodies by Rebai (1983)10.1021/ac000497v
/ Anal. Chem. / Sub-femtomole MS and MS/MS peptide sequence analysis using nano-HPLC micro-ESI fourier transform ion cyclotron resonance mass spectrometry by Martin (2000)10.1016/S1044-0305(98)00088-9
/ J. Am. Soc. Mass Spectrom. / Fragmentation of phosphopeptides in an ion trap mass spectrometer by DeGnore (1998)10.4049/jimmunol.156.7.2473
/ J. Immunol. / Importance of MHC class 1 α2 and α3 domains in the recognition of self and non-self MHC molecules by Newberg (1996)10.4049/jimmunol.164.5.2354
/ J. Immunol. / The density of peptides displayed by dendritic cells affects immune responses to human tyrosinase and gp100 in HLA-A2 transgenic mice by Bullock (2000)10.1084/jem.191.7.1221
/ J. Exp. Med. / Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigenimplications for tumor immunotherapy by Colella (2000)10.4049/jimmunol.152.6.2874
/ J. Immunol. / Naturally processed peptides longer than nine amino acid residues bind to the class I MHC molecule HLA-A2.1 with high affinity and in different conformations by Chen (1994)10.1016/1046-5928(92)90001-D
/ Protein Expr. Purif. / Immobilized metal ion affinity chromatography by Porath (1992)10.1016/S0021-9258(18)43911-7
/ J. Biol. Chem. / Identification by electrospray ionization mass spectrometry of the sites of tyrosine phosphorylation induced in activated Jurkat T cells on the protein tyrosine kinase ZAP-70 by Watts (1994)10.1006/abio.1996.0313
/ Anal. Biochem. / Selective detection and sequencing of phosphopeptides at the femtomole level by mass spectrometry by Carr (1996)10.1021/ac950875+
/ Anal. Chem. / Parent ion scans of unseparated peptide mixtures by Wilm (1996)10.1084/jem.181.4.1481
/ J. Exp. Med. / Processing of major histocompatibility class I–restricted antigens in the endoplasmic reticulum by Elliott (1995)10.1002/(SICI)1097-0282(1998)47:3<197::AID-BIP2>3.0.CO;2-H
/ Biopolymers. / Protein tyrosine kinasesstructure, substrate specificity, and drug discovery by al-Obeidi (1998)10.1074/jbc.274.51.36472
/ J. Biol. Chem. / Phosphorylation-dependent conformational changes induce a switch in the actin-binding function of MARCKS by Bubb (1999){'key': '2023072509173878700_R41', 'first-page': '5785', 'article-title': 'Two antigens recognized by autologous cytolytic T lymphocytes on a melanoma result from a single point mutation in an essential housekeeping gene', 'volume': '59', 'author': 'Chiari', 'year': '1999', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Two antigens recognized by autologous cytolytic T lymphocytes on a melanoma result from a single point mutation in an essential housekeeping gene by Chiari (1999)10.1016/0092-8674(91)90639-G
/ Cell. / Oncogenes and signal transduction by Cantley (1991)10.1016/0092-8674(91)90637-E
/ Cell. / Cooperation between oncogenes by Hunter (1991)10.1146/annurev.iy.12.040194.001145
/ Annu. Rev. Immunol. / Structure of peptides associated with class I and class II MHC molecules by Engelhard (1994)10.1006/smim.1993.1012
/ Semin. Immunol. / Consensus motifs and peptide ligands of MHC class I molecules by Falk (1993)10.1016/0968-0004(90)90073-K
/ Trends Biochem. Sci. / Protein kinase recognition sequence motifs by Kemp (1990)10.1038/nm0398-321
/ Nat. Med. / Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma by Rosenberg (1998)10.1007/BF00820664
/ Springer Semin. Immunopathol. / Direct identification of tumor-associated peptide antigens by Engelhard (1996)10.1016/S1074-7613(00)80101-6
/ Immunity. / The makings of a tumor rejection antigen by Gilboa (1999)10.1016/S0021-9258(17)37101-6
/ J. Biol. Chem. / Phosphorylation of the tumor suppressor protein p53 by mitogen-activated protein kinases by Milne (1994)
Dates
Type | When |
---|---|
Created | 23 years, 1 month ago (July 26, 2002, 12:48 p.m.) |
Deposited | 2 years, 1 month ago (July 25, 2023, 6:32 a.m.) |
Indexed | 1 week, 6 days ago (Aug. 19, 2025, 6:44 a.m.) |
Issued | 24 years, 8 months ago (Dec. 18, 2000) |
Published | 24 years, 8 months ago (Dec. 18, 2000) |
Published Online | 24 years, 8 months ago (Dec. 18, 2000) |
Published Print | 24 years, 8 months ago (Dec. 18, 2000) |
@article{Zarling_2000, title={Phosphorylated Peptides Are Naturally Processed and Presented by Major Histocompatibility Complex Class I Molecules in Vivo}, volume={192}, ISSN={1540-9538}, url={http://dx.doi.org/10.1084/jem.192.12.1755}, DOI={10.1084/jem.192.12.1755}, number={12}, journal={The Journal of Experimental Medicine}, publisher={Rockefeller University Press}, author={Zarling, Angela L. and Ficarro, Scott B. and White, Forest M. and Shabanowitz, Jeffrey and Hunt, Donald F. and Engelhard, Victor H.}, year={2000}, month=dec, pages={1755–1762} }